Form 8-K - Current report:
SEC Accession No. 0001564590-21-018899
Filing Date
2021-04-15
Accepted
2021-04-15 07:00:35
Documents
12
Period of Report
2021-04-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20210414.htm   iXBRL 8-K 34765
  Complete submission text file 0001564590-21-018899.txt   168518

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stro-20210414.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20210414_lab.xml EX-101.LAB 20227
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20210414_pre.xml EX-101.PRE 12084
5 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20210414_htm.xml XML 3679
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 21827258
SIC: 2836 Biological Products, (No Diagnostic Substances)